Throughout the last three months, 11 analysts have evaluated Corteva CTVA, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 6 | 2 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 3 | 6 | 2 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $64.18, with a high estimate of $69.00 and a low estimate of $57.00. This upward trend is evident, with the current average reflecting a 4.6% increase from the previous average price target of $61.36.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Corteva among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Begleiter | Deutsche Bank | Raises | Buy | $65.00 | $62.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $64.00 | $62.00 |
| Bobby Burleson | Canaccord Genuity | Raises | Buy | $65.00 | $60.00 |
| Richard Garchitorena | Wells Fargo | Raises | Overweight | $67.00 | $66.00 |
| Joel Jackson | BMO Capital | Raises | Outperform | $67.00 | $64.00 |
| Kristen Owen | Oppenheimer | Raises | Outperform | $69.00 | $67.00 |
| Edlain Rodriguez | Mizuho | Raises | Buy | $61.00 | $56.00 |
| Kristen Owen | Oppenheimer | Raises | Outperform | $67.00 | $62.00 |
| Jeffrey Zekauskas | JP Morgan | Lowers | Neutral | $57.00 | $58.00 |
| Benjamin Theurer | Barclays | Raises | Equal-Weight | $58.00 | $55.00 |
| Aleksey Yefremov | Keybanc | Raises | Overweight | $66.00 | $63.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Corteva. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Corteva compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Corteva's stock. This analysis reveals shifts in analysts' expectations over time.
Capture valuable insights into Corteva's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Corteva analyst ratings.
Discovering Corteva: A Closer Look
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
Breaking Down Corteva's Financial Performance
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Corteva's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company experienced a revenue decline of approximately -8.03%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 9.33%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Corteva's ROE excels beyond industry benchmarks, reaching 1.68%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Corteva's ROA stands out, surpassing industry averages. With an impressive ROA of 0.97%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Corteva's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.19.
The Core of Analyst Ratings: What Every Investor Should Know
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
